30 min listen
Interview with Dr. Jeffery Klco and Dr. Timothy Ley: Day-30 Mutation Analysis after AML Induction
FromThe Hematologist
Interview with Dr. Jeffery Klco and Dr. Timothy Ley: Day-30 Mutation Analysis after AML Induction
FromThe Hematologist
ratings:
Length:
40 minutes
Released:
Nov 10, 2015
Format:
Podcast episode
Description
In her Diffusion article from the November/December issue of The Hematologist, Dr. Pamela Becker (Institute for Stem Cell and Regenerative Medicine and Center for Cancer Innovation, University of Washington, Seattle, WA) talks about the many mutations identified in acute myeloid leukemia (AML) and the efforts of investigators to find a practical application of this information in modifying treatment. Dr. Jeffry Klco (St. Jude Children’s Research Hospital, Memphis, TN) and Dr. Timothy Ley (McDonnell Genome Institute and Siteman Cancer Center, Washington University, St. Louis, MO), co-authors of the JAMA article join Dr. Becker in this discussion. You can find the diffusion online at www.hematology.org/Thehematologist/Diffusion/4487.aspx.
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Music: “Jellyfish in Space” Kevin MacLeod (incompetech.com). Licensed under Creative Commons: By Attribution 3.0 creativecommons.org/licenses/by/3.0/
Released:
Nov 10, 2015
Format:
Podcast episode
Titles in the series (100)
Heparin-Induced Thrombocytopenia: A Preventable Nosocomial Disease: In his Diffusion article from the July/August issue of The Hematologist, Dr. Adam Cuker (University of Pennsylvania) covers options to reduce the incidence of heparin-induced thrombocytopenia (HIT), treating it as a preventable nosocomial disease rather t by The Hematologist